Natus Medical Incorporated
Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally. The company sells energy storage systems and fittings, as well as valve or spare part; and manufactures various products, such as portable valve grinding equipment, electric steam boilers, customized steam systems, molds, tool… Read more
Natus Medical Incorporated (NM4) - Total Liabilities
Latest total liabilities as of September 2025: €256.45 Million EUR
Based on the latest financial reports, Natus Medical Incorporated (NM4) has total liabilities worth €256.45 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Natus Medical Incorporated - Total Liabilities Trend (2014–2024)
This chart illustrates how Natus Medical Incorporated's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Natus Medical Incorporated Competitors by Total Liabilities
The table below lists competitors of Natus Medical Incorporated ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AXMIN Inc
PINK:AXMIF
|
USA | $941.80K |
|
Tongda Group Holdings Limited
F:TJC
|
Germany | €4.25 Billion |
|
Pasdec Holdings Bhd
KLSE:6912
|
Malaysia | RM37.82 Million |
|
Adgar Investments and Development Ltd
TA:ADGR
|
Israel | ILA4.13 Billion |
|
Welsis Corp.
OTCGREY:WLSS
|
USA | $152.50K |
|
Marley Spoon Group SE
XETRA:MS1
|
Germany | €133.04 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Natus Medical Incorporated's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -35.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Natus Medical Incorporated's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Natus Medical Incorporated (2014–2024)
The table below shows the annual total liabilities of Natus Medical Incorporated from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €245.80 Million | -2.53% |
| 2023-12-31 | €252.17 Million | +80.85% |
| 2022-12-31 | €139.44 Million | -0.07% |
| 2021-12-31 | €139.54 Million | -26.29% |
| 2020-12-31 | €189.30 Million | -8.29% |
| 2019-12-31 | €206.40 Million | -13.89% |
| 2018-12-31 | €239.70 Million | -16.72% |
| 2017-12-31 | €287.82 Million | +24.26% |
| 2016-12-31 | €231.64 Million | +160.89% |
| 2015-12-31 | €88.79 Million | +8.14% |
| 2014-12-31 | €82.11 Million | -- |